Original research
par
Mocanu, Victor et al
Date de publication
2023
Géographie
Canada
Langue de la ressource
English
Texte disponible en version intégrale
Non
Open Access / OK to Reproduce
Non
Évalué par des pairs
Yes
L’objectif
This study evaluated the impact of initial randomized OAT allocation on subsequent switching among people with prescription-type opioid use disorder (POUD).
Constatations/points à retenir
OAT switching was common in this sample of individuals with POUD, with individuals randomly allocated to buprenorphine/naloxone being more than twice as likely to switch versus methadone. This may reflect a stepped care approach in OUD management.
La conception ou méthodologie de recherche
Secondary analysis of a 24-week Canadian multicenter, pragmatic, randomized trial conducted (n=272) between 2017 and 2020 comparing flexible take-home buprenorphine/naloxone versus supervised methadone models of care for POUD
Mots clés
Substitution/OAT
Transitions in care/treatment
